Publications

Abul-Husn NS, Owusu Obeng A, Sanderson SC, Gottesman O, Scott SA (2014). Implementation and utilization of genetic testing in personalized medicine. Pharmgenomics Pers Med 7: 227-240. [Pubmed]

Overby CL, Ludtke Erwin A, Abul-Husn NS, Ellis SB, Scott SA, Owusu Obeng A, Kannry JL, Hripcsak G, Bottinger EP, Gottesman O (2014). Physician attitudes toward adopting genome-guided prescribing through clinical decision support. J Pers Med 4(1): 35-49. [Pubmed]

Abul-Husn NS, Annangudi SP, Ma’ayan A, Ramos-Ortolaza DL, Stockton SD Jr, Gomes I, Sweedler JV, Devi LA (2011). Chronic morphine alters the presynaptic protein profile: Identification of novel molecular targets using proteomics and network analysis. PLoS ONE 6(10): e25535. doi:10.1371/journal.pone.0025535. [Pubmed]

Ramos-Ortolaza DL, Bushlin I, Abul-Husn N, Annagudi SP, Sweedler J, Devi LA (2010). Quantitative neuroproteomics of the synapse. Methods Mol Biol 615: 227-246. [Pubmed]

Abul-Husn NS, Bushlin I, Morón JA, Jenkins SL, Dolios G, Wang R, Iyengar R, Ma’ayan A & Devi LA (2009). Systems approach to explore components and interactions in the presynapse. Proteomics 9(12): 3303-3315. [Pubmed]

Ma’ayan A, Jenkins SL, Webb RL, Berger SI, Purushothaman SP, Abul-Husn NS, Posner JM, Flores T & Iyengar R (2009). SNAVI: Desktop application for analysis and visualization of large-scale signaling networks. BMC Systems Biology 3: 10. [Pubmed]

Rozenfeld R, Abul-Husn NS, Gomes I, & Devi LA (2007). An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. ScientificWorldJournal 7: 64-73. [Pubmed]

Abul-Husn NS, Sutak M, Milne B, & Jhamandas K (2007). Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu and delta receptor antagonists. Br J Pharmacol 151(6): 877-887. [Pubmed]

Morón JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, & Devi LA (2007). Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol Cell Proteomics 6(1): 29-42. [Pubmed]

Abul-Husn NS & Devi LA (2006). Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther 318(2): 461-468. [Pubmed]

Powell KJ, Abul-Husn NS, Jhamandas A, Olmstead MC, Beninger RJ, & Jhamandas K (2002). Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 300(2): 588-596. [Pubmed]

Book Chapters

Abul-Husn NS & Nestler EJ (2013). “Genetics of drug addiction”. In: Clinical Genomics: Practical Applications in Adult Patient Care (Michael Murray, Mark Babyatski, Monica Giovanni, editors). McGraw-Hill, New York, 681-685.

Abul-Husn NS, Gupta A, Devi LA, & Gomes I (2005). “Modulation of receptor pharmacology by G protein-coupled receptor dimerization”. In: The G Protein-Coupled Receptors Handbook (Devi LA, editor). The Humana Press Inc., New Jersey, 323-346.